US Patent 10537638 Low concentration antibody formulations
Patent 10537638 was granted and assigned to GlaxoSmithKline on January, 2020 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10537638 Low concentration antibody formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
